About

Qualifications

Neovacs’ Board consists of six experienced directors, from varied professional backgrounds. Two Board Members are Independent Directors.

Members

Jean-Jacques Bertrand

Ex-Chairman of Pierre Fabre Group and Guerbet S.A
Ex-Former Chairman and CEO of Aventis Pasteur and former chairman of the French pharmaceutical industry association LEEM

 

Miguel Sieler

C.E.O of Neovacs

 

Daniel Zagury, MD, PhD

Founder of Neovacs

 

Arlene Morris (independent Director)

Director of MUSC Foundation for Research and Development and BIO (U.S.A)

25 years of management experience from Johnson & Johnson’s, Ortho-McNeil Pharmaceutical, Scios, Inc.,
Corixa Corporation and Clearview Projects, Inc.

Chief Executive Officer of Willow Advisors, LLC since 2015

She served as Director of Palatin Technologies Inc. and as a Director of Biodel Inc. since  2015

Ex-Chief Executive Officer and President of Syndax Pharmaceuticals, Inc. from  2013 to  2015

Ex-Director of Medicinova Inc. from May 11, 2006 to June 14, 2013

Ex-Chief Executive Officer of Affymax, Inc. from 2003 to 2011

 

Patrick Valroff (independent Director)

Graduate from the IEP Paris and ENA

Ex-Chief Executive Officer at Crédit Agricole Corporate and Investment Bank S.A. and Executive Board member  at Credit Agricole SA

He served as Head Clerk in the budget department of the French government

 

Jacques Banchereau, Ph.D.

President of Neovacs’ Scientific Advisory Board

Jackson Laboratory for Genomic Medicine, Farmington, Conn. (U.S.A)

 

Nous retrouver

NEOVACS S.A.

3-5, Impasse Reille

75014 PARIS

FRANCE

 

Tel. : 33 (0)1 53 10 93 00

Fax : 33 (0)1 53 10 93 03

POURQUOI INVESTIR ?

VOIR L’ESPACE INVESTISSEURS